Prospective randomised study of reverse shoulder prosthesis and hemiarthroplasty for elderly patients with proximal humeral fractures
ISRCTN | ISRCTN32335957 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN32335957 |
Secondary identifying numbers | 3474 |
- Submission date
- 14/03/2007
- Registration date
- 09/05/2007
- Last edited
- 11/10/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English Summary
Not provided at time of registration
Contact information
Mr C Sinopidis
Scientific
Scientific
Link 4Z
Royal Liverpool and Broadgreen University Hospitals
Prescot Street
Liverpool
L7 8XP
United Kingdom
Study information
Study design | Double-blind randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
Scientific title | Prospective randomised study of Reverse shoulder Prosthesis and Hemiarthroplasty for elderly patients with proximal humeral fractures |
Study acronym | Reverse Prosthesis vs Hemiarthroplasty |
Study hypothesis | The aim is to find which of the two (Reverse Shoulder Prosthesis or Hemiarthroplasty) is the better prosthesis in the elderly patients, with a shoulder fracture and need for arthroplasty. |
Ethics approval(s) | Central Office for Research Ethics Committee and Liverpool Local Research Ethics Committee, 10/10/2007, ref: 07/Q1502/59 |
Condition | Elderly patients with shoulder fracture that require arthroplasty |
Intervention | Either a Reverse Shoulder Prosthesis or a Hemiarthroplasty for the fracture. All other aspects of treatment including follow up will be the same. |
Intervention type | Procedure/Surgery |
Primary outcome measure | 1. Activities of daily living of American Shoulder and Elbow Surgeons (ASES) 2. Simple shoulder test These will be measured at one year after the operation |
Secondary outcome measures | 1. 36-item Short Form health survey (SF-36) 2. University of California and Los Angeles (UCLA) scores 3. Radiological outcome These will be measured at one year after the operation |
Overall study start date | 01/06/2007 |
Overall study end date | 31/05/2008 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Senior |
Sex | Both |
Target number of participants | 120 |
Participant inclusion criteria | 1. Elderly patients who require arthroplasty for shoulder fracture 2. Patients agreeing to participate in the study 3. Patients who are able to give consent |
Participant exclusion criteria | 1. Patients who are younger than 70 years 2. Poly-trauma patients 3. Multiple fractures 4. Open fracture 5. Previous operation to the shoulder 6. Dementia 7. Nerve or vessel injury 8. Unable to understand English |
Recruitment start date | 01/06/2007 |
Recruitment end date | 31/05/2008 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Royal Liverpool and Broadgreen University Hospitals
Liverpool
L7 8XP
United Kingdom
L7 8XP
United Kingdom
Sponsor information
Royal Liverpool and Broadgreen University Hospital NHS Trust (UK)
Hospital/treatment centre
Hospital/treatment centre
Prescot Street
Liverpool
L7 8XP
England
United Kingdom
Website | http://www.rlbuht.nhs.uk/ |
---|---|
https://ror.org/009sa0g06 |
Funders
Funder type
Government
Royal Liverpool and Broadgreen University Hospital NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
11/10/2017: No publications found, verifying study status with principal investigator.